ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
84.005
0.45%
US Dollar vs AUD
1.51946
-0.16%
Bitcoin
59,285.19
0.28%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. OptiNose Inc (OPTN)

  7. OptiNose Inc (OPTN) News

OPTN OptiNose Inc

0.8779
0.0003 (0.03%)
Pre Market
Last Updated: 19:35:43
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
OptiNose Inc OPTN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0003 0.03% 0.8779 19:35:43
Open Price Low Price High Price Close Price Previous Close
0.8776
more quote information »

Recent News

Date Time Source Heading
25/4/202421:00GLOBEOptinose Provides Corporate Update on XHANCE Launch and..
05/4/202407:01GLOBEOptinose to Present at the Needham Virtual Healthcare..
16/3/202406:34GLOBEXHANCE Approved by FDA as First and Only Medication..
09/3/202408:10EDGAR2Form 8-K - Current report
08/3/202408:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202423:00GLOBEOptinose Reports Fourth Quarter and Full Year 2023 Financial..
07/3/202423:00EDGAR2Form 8-K - Current report
01/3/202408:40GLOBEOptinose Announces Reporting Date for Fourth Quarter 2023..
01/3/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:08EDGAR2Form 8-K - Current report
23/2/202408:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202412:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202404:00GLOBEOptinose Announces the Publication of ReOpen Phase 3..
22/12/202308:11EDGAR2Form 8-K - Current report
21/12/202304:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202304:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202300:48DJNOptinose Shares Slide Premarket as FDA Extends Xhance Review
06/12/202323:02EDGAR2Form 8-K - Current report
06/12/202323:00GLOBEOptinose Announces 3-Month Extension of FDA Review Period..
23/11/202301:00GLOBEOptinose to Present at the 35th Annual Piper Sandler..
09/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:02EDGAR2Form 8-K - Current report
09/11/202323:00GLOBEOptinose Reports Third Quarter 2023 Financial Results and..
27/10/202323:00GLOBEOptinose Announces Reporting Date for Third Quarter 2023..
22/9/202323:01GLOBEOptinose to Present at the 2023 Cantor Global Healthcare..
20/9/202309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202309:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202306:05EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202321:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202321:02EDGAR2Form 8-K - Current report
10/8/202321:00GLOBEOptinose Reports Second Quarter 2023 Financial Results and..
27/7/202321:27EDGAR2Form 8-K - Current report
27/7/202321:00GLOBEOptinose Announces Preliminary Second Quarter 2023 XHANCE..
17/6/202306:08GLOBEOptinose Announces Inducement Grant Under Nasdaq Listing..
03/6/202303:00GLOBEOptinose to Present at the Jefferies Healthcare Conference
11/5/202321:00GLOBEOptinose Reports First Quarter 2023 Financial Results and..
04/5/202321:00GLOBEOptinose Announces FDA Acceptance of Supplemental New Drug..

Your Recent History

NASDAQ
OPTN
OptiNose
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved